- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06141915
Aerobic Training and Diet Protocol on Immune System in Burn Patients.
Aerobic Training Combined With Diet Protocol on Immune System in Burn Patients.
Aerobic exercises can produce immediate and short-term improvements in the immune response of leukocytes, T-lymphocytes, lymphocyte subpopulations, interleukins, and immunoglobulins. Even only a single session of aerobic exercises produces improvements in the utmost immune markers, such as T-lymphocytes, leukocytes, and immunoglobulins.
Also, burned patients suffer from post-traumatic stress and stress can cause this alteration through its effect on increasing the amounts of serum corticosteroid and catecholamine hormones, thus a decrease in the immunity response might occur. Increasing the aerobic capacity can significantly improve the mood. This might be attributed to the effect of aerobic exercises on decreasing stress hormones, like corticosteroids and catecholamines hormones.
The altered metabolism post major burn also affects the immune system in burn patients and the aerobic training enhances the metabolism, body composition and the lean mass and so, enhances the immune system.
One of the most important factors for a good and effective immune system is the balanced diet especially diet rich in vitamin D, fibers, and multiple nuts and seeds such as almond, walnut, pistachio, sunflower seeds, flax seeds and sesame seed that have an crucial role in improving the immune system either acting on it directly or indirectly by enhancing the general heath of the body and the patients mood.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Group A (Aerobic training and diet protocol group): patients will be engaged in aerobic training using treadmill three times per week, for 12 weeks. The exercise intensity will be 50-70% of each patient's maximum heart rate. Each exercise session will consist of three phases; five-minutes warming up phase in form of stretching exercises and walking on the treadmill at the slowest speed, 20-minutes conditioning phase in form of walking on the treadmill at 50% of participants' maximum heart rate in the first two weeks then progressed gradually to reach the 70% of maximum heart rate by the 12th weeks", and five-minutes cool down phase that will be constant as warming up phase. During the training, the patient's blood pressure, heart rate, and breathing pattern will be frequently monitored . Also, the will be asked to follow a diet protocol designed by the nutrition specialist that rich in in vitamin D, fibers, and multiple nuts and seeds such as almond, walnut, pistachio, sunflower seeds, flax seeds and sesame seed to improve immune system for 12 weeks.
Group B (Aerobic training group): Patients will practice the aerobic training only like that of group A for 30 minutes, three sessions per week for 12 weeks.
Group C (Diet protocol group): Patients will only follow the same diet protocol that will be prescribed to group A for 12 weeks All patients in all groups will receive the same medical and traditional physical therapy in form of proper positioning and splinting and stretching, RoM, graduated strengthening exercises.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: A G Elsayed, PHD
- Phone Number: 02 01001475959
- Email: drayasa3ada@yahoo.com
Study Locations
-
-
-
Giza, Egypt, 3387722
- Recruiting
- Faculty of physical therapy, Cairo University
-
Contact:
- Aya G Elsayed, PHD
- Phone Number: 02 01001475959
- Email: drayasa3ada@yahoo.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients from both genders.
- The age ranges from 25 to 40 years.
- Weight range 60-85 kg, height 155- 170 cm.
- Total burned surface area (TBSA) was 20- 40% measured by the rule of nines.
- Thermal burn.
- Burn depth, partial-thickness burn injury.
- Patient will participate in the study one month after discharge.
Exclusion Criteria:
- Inhalation injury.
- Leg amputation.
- Any limitation in LL range of motion.
- Auditory or visual problems.
- Congenital musculoskeletal deformities, especially in the foot.
- Psychiatric disorders.
- Paralysis.
- Cardiac abnormalities or cardiac pacemakers.
- Patients who participated in any rehabilitation program before the study that may affect our results.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Aerobic training and diet protocol group
30 patients received aerobic training and diet protocol for 12 weeks.
|
patients will be engaged in aerobic training using treadmill three times per week, for 12 weeks.
The exercise intensity will be 50-70% of each patient's maximum heart rate.
Each exercise session will consist of three phases; five-minutes warming up phase in form of stretching exercises and walking on the treadmill at the slowest speed, 20-minutes conditioning phase in form of walking on the treadmill at 50% of participants' maximum heart rate in the first two weeks then progressed gradually to reach the 70% of maximum heart rate by the 12th weeks", and five-minutes cool down phase that will be constant as warming up phase.
During the training, the patient's blood pressure, heart rate, and breathing pattern will be frequently monitored
|
|
Experimental: Aerobic training group
30 patients will receive aerobic training for 30 minutes, three times per week for 12 weeks.
|
patients will be engaged in aerobic training using treadmill three times per week, for 12 weeks.
The exercise intensity will be 50-70% of each patient's maximum heart rate.
Each exercise session will consist of three phases; five-minutes warming up phase in form of stretching exercises and walking on the treadmill at the slowest speed, 20-minutes conditioning phase in form of walking on the treadmill at 50% of participants' maximum heart rate in the first two weeks then progressed gradually to reach the 70% of maximum heart rate by the 12th weeks", and five-minutes cool down phase that will be constant as warming up phase.
During the training, the patient's blood pressure, heart rate, and breathing pattern will be frequently monitored
|
|
Active Comparator: Diet protocol group
30 patients will receive diet protocol for 12 weeks.
|
diet protocol
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The immune markers
Time Frame: Three months
|
total lymphocyte count (TLC) in 10^9 cells/liter will be measured
|
Three months
|
|
Neutrophil to lymphocyte ratio (NLR)
Time Frame: Three months
|
The immune markers
|
Three months
|
|
Platelet to lymphocyte ratio (PLR)
Time Frame: Three months
|
The immune markers
|
Three months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Arabic version of post traumatic stress disorder PTSD Checklist Civilian Version
Time Frame: Three months
|
It is a 17-item self-report scale that measures PTSD symptom severity
|
Three months
|
|
The quality of life (QoL)
Time Frame: Three months
|
Burn Specific Health Scale-Brief (BSHS-B) questionnaire will be used for the assessment of general, physical, mental, and social health aspects of the burn survivors
|
Three months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: A G Elsayed, PHD, Cairo University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T.REC/012/004579
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Immune System Disorder
-
Kadmon, a Sanofi CompanyCompletedImmune System Disorder (Healthy Volunteer)United States
-
Kadmon, a Sanofi CompanyCompletedImmune System Disorder (Healthy Volunteer)United States
-
Kadmon, a Sanofi CompanyCompletedImmune System Disorder (Healthy Volunteer)United States
-
University of HelsinkiTampere UniversityCompletedImmune System DisordersFinland
-
SanofiTerminatedImmune System DisorderUnited States, Spain
-
Shanghai Henlius BiotechCompleted
-
Universitätsklinikum Hamburg-EppendorfRecruitingPregnancy | Immune System DisorderGermany
-
University of New MexicoRecruitingDNA Damage | Immune System DisorderUnited States
-
Kadmon, a Sanofi CompanyCompletedHealthy Volunteers | Immune System DisorderUnited States
-
Xiangya Hospital of Central South UniversityUnknownSepsis | Inflammatory Disorder of Immune System
Clinical Trials on Aerobic training
-
University of BarcelonaCompleted
-
General Hospital Murska SobotaUniversity of Primorska; University of LjubljanaUnknownCoronary Artery Disease | Heart Failure With Reduced Ejection FractionSlovenia
-
Hadassah Medical OrganizationCompletedThe Influence of Different Training Regimens on Electrical Stability Following Myocardial InfarctionIschemic Heart Disease | Congestive Heart FailureIsrael
-
Riphah International UniversityCompleted
-
Riphah International UniversityCompletedMyocardial InfarctionPakistan
-
Clare MaguireRehab Basel; Bildungszetrum Gesundheit Basel-StadtCompleted
-
University of GiessenHannover Medical SchoolUnknownType 2 DiabetesGermany
-
Cardenal Herrera UniversityNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Duke UniversityCompleted
-
UNC Lineberger Comprehensive Cancer CenterCompletedStem Cell Transplantation, HematopoieticUnited States